John P. Gonzalez

1.2k total citations
26 papers, 918 citations indexed

About

John P. Gonzalez is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, John P. Gonzalez has authored 26 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in John P. Gonzalez's work include Pain Mechanisms and Treatments (8 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Receptor Mechanisms and Signaling (7 papers). John P. Gonzalez is often cited by papers focused on Pain Mechanisms and Treatments (8 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Receptor Mechanisms and Signaling (7 papers). John P. Gonzalez collaborates with scholars based in United Kingdom, France and United States. John P. Gonzalez's co-authors include Rex N. Brogden, Robert D. E. Sewell, Ronald A. Young, Eugene M. Sorkin, Peter A. Todd, P.S. Spencer, Stephen P. Clissold, S. Barasi, James I. Robertson and N. Upton and has published in prestigious journals such as British Journal of Pharmacology, Life Sciences and European Journal of Pharmacology.

In The Last Decade

John P. Gonzalez

26 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John P. Gonzalez United Kingdom 13 258 229 220 191 137 26 918
Samson Symchowicz United States 22 194 0.8× 124 0.5× 204 0.9× 268 1.4× 90 0.7× 58 1.2k
Steven Peikin United States 17 234 0.9× 383 1.7× 175 0.8× 332 1.7× 115 0.8× 42 1.2k
L Chevillard France 15 167 0.6× 169 0.7× 116 0.5× 148 0.8× 41 0.3× 67 845
Marvin E. Rosenthale United States 18 235 0.9× 107 0.5× 441 2.0× 207 1.1× 111 0.8× 53 1.1k
Philip A. Krieter United States 15 75 0.3× 205 0.9× 157 0.7× 175 0.9× 119 0.9× 21 792
Karen J. McClellan New Zealand 27 139 0.5× 111 0.5× 205 0.9× 263 1.4× 274 2.0× 37 2.4k
M.Maureen Dale United Kingdom 15 341 1.3× 99 0.4× 150 0.7× 395 2.1× 62 0.5× 47 1.4k
Sue Aspley United Kingdom 19 218 0.8× 229 1.0× 403 1.8× 234 1.2× 41 0.3× 41 1.3k
Gaston Labrecque Canada 20 281 1.1× 123 0.5× 233 1.1× 152 0.8× 66 0.5× 60 1.1k
Charles Locke United States 20 189 0.7× 93 0.4× 163 0.7× 192 1.0× 121 0.9× 54 1.4k

Countries citing papers authored by John P. Gonzalez

Since Specialization
Citations

This map shows the geographic impact of John P. Gonzalez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Gonzalez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Gonzalez more than expected).

Fields of papers citing papers by John P. Gonzalez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Gonzalez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Gonzalez. The network helps show where John P. Gonzalez may publish in the future.

Co-authorship network of co-authors of John P. Gonzalez

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Gonzalez. A scholar is included among the top collaborators of John P. Gonzalez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Gonzalez. John P. Gonzalez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Constance M., Marita A. Wallace, Amita Arora, et al.. (2023). Prolonged voluntary wheel running reveals unique adaptations in mdx mice treated with microdystrophin constructs ± the nNOS-binding site. Frontiers in Physiology. 14. 1166206–1166206. 4 indexed citations
2.
Gonzalez, John P., et al.. (1989). Lofepramine. Drugs. 37(2). 123–140. 63 indexed citations
3.
Gonzalez, John P., et al.. (1989). Pefloxacin. Drugs. 37(5). 628–668. 63 indexed citations
4.
Sewell, Robert D. E., et al.. (1989). Novel Inhibitors of Enkephalin-Degrading Enzymes I: Inhibitors of Enkephalinase by Penicillins. Journal of enzyme inhibition. 3(2). 91–101. 5 indexed citations
5.
Yu, Zhengquan, et al.. (1989). Novel Inhibitors of Enkephalin-Degrading Enzymes II: N5-Substituted-4-Thioxohydantoic Acids as Aminopeptidase Inhibitors. Journal of enzyme inhibition. 3(2). 103–117. 2 indexed citations
6.
Young, Ronald A., John P. Gonzalez, & Eugene M. Sorkin. (1989). Roxithromycin. Drugs. 37(1). 8–41. 115 indexed citations
7.
Gonzalez, John P., et al.. (1989). Dothiepin. Drugs. 38(1). 123–147. 29 indexed citations
8.
Gonzalez, John P. & Rex N. Brogden. (1988). Naltrexone. Drugs. 35(3). 192–213. 238 indexed citations
9.
Gonzalez, John P. & Rex N. Brogden. (1987). Nedocromil Sodium. Drugs. 34(5). 560–577. 66 indexed citations
10.
Gonzalez, John P. & Stephen P. Clissold. (1987). Ocular Levobunolol. Drugs. 34(6). 648–661. 20 indexed citations
11.
Gonzalez, John P. & Peter A. Todd. (1987). Tenoxicam. Drugs. 34(3). 289–310. 75 indexed citations
12.
Casal, M., et al.. (1987). In vitro susceptibility of Mycobacterium tuberculosis to a new macrolide antibiotic: RU-28965. Tubercle. 68(2). 141–143. 10 indexed citations
13.
Barasi, S., et al.. (1987). Dopamine receptor‐mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390. British Journal of Pharmacology. 90(1). 15–22. 48 indexed citations
14.
Gonzalez, John P., A. J. McCulloch, Paul J. Nicholls, Robert D. E. Sewell, & A. Tekle. (1984). SUBACUTE BENZODIAZEPINE TREATMENT: OBSERVATIONS ON BEHAVIOURAL TOLERANCE AND WITHDRAWAL. Alcohol and Alcoholism. 19(4). 325–32. 13 indexed citations
15.
Sewell, Robert D. E., et al.. (1984). Comparison of the relative effects of aspirin, mefenamic acid, dihydrocodeine, dextropropoxyphene and paracetamol on visceral pain, respiratory rate and prostaglandin biosynthesis.. PubMed. 268(2). 325–34. 7 indexed citations
16.
Gonzalez, John P., et al.. (1984). MEPTAZINOL ACTIVITY ON MORPHINE-NAIVE AND MORPHINE-DEPENDENT GUINEA-PIG ILEUM: CORRELATION WITH <italic>IN VIVO</italic> STUDIES. Alcohol and Alcoholism. 19(4). 333–8. 2 indexed citations
17.
Gonzalez, John P., et al.. (1983). THE INFLUENCE OF SELECTIVE DOPAMINERGIC AND CHOLINERGIC AGONISTS AND ANTAGONISFS ON PRECIPITATED OPIATE ABSTINENCE. Alcohol and Alcoholism. 6 indexed citations
18.
Gonzalez, John P., et al.. (1983). Effects of elevated calcium and calcium antagonists on 6,7-benzomorphan-induced analgesia. European Journal of Pharmacology. 90(4). 385–391. 60 indexed citations
19.
Davies, W.T., John P. Gonzalez, Robert D. E. Sewell, & P.S. Spencer. (1983). THE EFFECTS OF SOME ANTIDEPRESSANTS ON THE INDUCTION OF MORPHINE DEPENDENCE AND THE MORPHINE WITHDRAWAL SYNDROME. Alcohol and Alcoholism. 2 indexed citations
20.
Gonzalez, John P., Robert D. E. Sewell, & P.S. Spencer. (1981). Dopaminergic involvement in the hyperalgesic effect of nomifensine. Life Sciences. 28(8). 951–956. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026